You are viewing the site in preview mode
Skip to main content
|
Pair no.
|
Case no.a
|
BA
|
Diagnosis
|
Age (years)b
|
Sex
|
PMI (h)c
|
Cause of death
|
Intellectual disability
|
Epilepsy
|
Other features
|
Drug therapies at time of deathd
|
|---|
|
1
|
AN11989 (B6677)
|
41/42
|
Autism
|
20
|
M
|
16
|
Cardiac arrest
|
Yes
|
Yes
|
–
|
Heart medication, Zoloft, clomipramine
|
|
2
|
AN08792 (B5173)
|
41/42
|
Autism
|
30
|
M
|
20
|
Gastrointestinal hemorrhage
|
Yes
|
Yes
|
Large ear lobes
|
Dilantin, Depakote, Tranxene bid, cisapride, clorazepate, folic acid, oxcarbazepine
|
|
3
|
AN00764 (B5144)
|
22
|
Autism
|
20
|
M
|
23.7
|
Trauma
|
Yes
|
No
|
–
|
None
|
|
4
|
AN17138 (B6294)
|
41/42
|
Autism
|
16
|
M
|
Unknown
|
Seizure
|
Unknown
|
Yes
|
Inherited 15q duplication
|
Topamax, Depakote, Allegra, Claritin, NuThera multivitamin
|
|
5
|
AN09730 (B6337)
|
22
|
Autism
|
22
|
M
|
25
|
Seizure
|
Yes
|
Yes
|
Intestinal lymphadenopathy, hypertrophic spleen, recurrent otitis
|
Lamictal, Zonegran, Neurontin, Abilify, flax seed oil, omega-3, multivitamin
|
|
6
|
AN01570 (B6184)
|
41/42
|
Autism
|
18
|
F
|
6.75
|
Seizure
|
Unknown
|
Yes
|
Focal slowing in the left parieto-occipital area
|
None
|
|
1
|
AN10833 (B5718)
|
41/42
|
Control
|
22
|
M
|
21.5
|
Unknown
|
No
|
No
|
–
|
None
|
|
2
|
B4211
|
41/42
|
Control
|
30
|
M
|
23
|
Cardiac arrhythmia
|
No
|
No
|
–
|
None
|
|
3
|
AN04432 (B3829)
|
22
|
Control
|
22
|
M
|
12
|
Central hepatic laceration
|
No
|
No
|
–
|
None
|
|
4
|
AN17425 (B6207)
|
22
|
Control
|
16
|
M
|
26
|
Ischemic heart attack
|
No
|
No
|
–
|
None
|
|
5
|
AN14368 (B6221)
|
41/42
|
Control
|
22
|
M
|
24
|
Unknown
|
No
|
No
|
–
|
None
|
|
6
|
UMB1541
|
22
|
Control
|
20
|
F
|
19
|
Head injuries
|
No
|
No
|
–
|
None
|
-
BA Brodmann area, PMI post-mortem interval
-
aAutism Tissue Program identifier
-
bMean age (±SD) for the autism group = 21.0±2.9, for controls = 22.0±1.8; t = −0.368, df = 10, p = 0.721
-
cMean PMI (±SD) for the autism group = 18.2+3.2, for controls = 20.9±2.0, t = −0.707, df = 9, p = 0.497
-
dPharmacological therapy from the last available report, dating back to less than a year prior to death
